Note 03.B: TERMS/RIGHT ATTACHED TO EQUITY SHARES
The company has only one class of shares i.e. Equity Shares having a face value of' 10 each. Each shareholder is eligible for one vote per share held. In the event of liquidation, the equity shareholders are eligible to receive the remaining assets of the company after distribution of all preferential amounts, in proportion to their shareholding.
Note 24 : SEGMENT REPORTING
As the Company's business activity falls within a single business segment, viz. "Trading in pharmaceutical products", the disclosure requirements of Accounting Standard (AS-17) on "Segment Reporting", notified by the companies (Accounting Standards) Rules, 2006, are not applicable.
NOTE 27 : DISCLOSURE UNDER MICRO, SMALL AND MEDIUM ENTERPRISES DEVELOPMENT ACT, 2006.
The Company has not received the required information from suppliers regarding their status under Micro, Small and Medium Enterprises Development Act, 2006. Hence, disclosures, if any, relating to the amounts unpaid as at the year end together with the interest paid/payable as required under the said Act have not been made.
NOTE 28 : EMPLOYEE BENEFITS
As per the present practice followed by the company, the Payment of Gratuity is charged to statement of Profit & Loss in the year the employee leaves/retires from the company. The company does not make provision for Gratuity on an accrual basis as per the accurial valuation at the close of the year towards the present employees of the company as required by Accounting Standard AS 15 (Revised) as prescribed by the Institute of Chartered Accountants of India.
NOTE 29 : OHER STATUTORY INFORMATION
i) There are no transactions during the year with struck off companies as at 31 March 2025.
ii) The company has not traded or invested in crypto currency or Virtual currency during the year.
iii) During the year the Company has not advanced or loaned or invested funds (either borrowed funds or share premium or any other sources or kind of funds) to any other person or entity including foreign entities (intermediaries) with the understanding (whether recorded in writing or otherwise) that the intermediary shall (i) directly or indirectly lend or invest in other person or entities identified in any manner whatsoever by or on behalf of company (ultimate beneficiaries) or (ii) provide any guarantee, security or the like to or behalf of the ultimate beneficiaries. The company has not given any loans except loans to employees and made inventories in the marketable equity shares. The company has not given guarantee or provided security.
iv) The company has not traded or invested in crypto currency or Virtual currency during the year.
v) The Company has not received any fund from any person(s) or entity(ies) including foreign entities (funding party) with the understanding (whether recorded in writing or otherwise) that the Company shall (i) directly or indirectly lender invest in any manner whatsoever by or on behalf of the funding party (ultimate beneficiaries) or (ii) provide any guarantee, security or the to or behalf of the (ultimate beneficiaries) or (iii) provide any guarantee, security or the like to or on behalf of the ultimate beneficiaries.
vi) No proceedings are initiated or pending against the company for holding benami property under the Benami Transactions (Prohibition) Act, 1988 (45 of 1988)
|
NOTE 30 : CONTINGENT LIABILITY
|
|
(Rs. in Lacs)
|
|
Particulars
|
As at 31st March 2025
|
As at 31st March 2024
|
|
Contingent liabilities (to the extent not provided for)
Income tax matters
Claims against company not against debt GST Matters
|
655.03
|
|
|
Contingent liabilities (to the extent not provided for)
Estimated amounts of contracts remaining to be executed on capital account and not provided for (net of advances)
|
|
|
|
Other
|
|
|
|
Total > > > > >
|
655.03
|
-
|
NOTE 31 : PREVIOUS YEAR COMPARATIVE
Previous year's figures have been regrouped/reclassified wherever necessary to correspond with the current year's classification/disclosure.
|